# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Systemic Lupus Erythematosus
- **MONDO ID:**  (if available)
- **Category:** Complex

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Systemic Lupus Erythematosus**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** cyberian
**Generated:** 2026-02-01T14:47:49.161854

1. baechler-2003-interferon-signature-severe-sle-abstract.md
2. baechler-2003-interferon-signature-severe-sle-summary.md
3. bennett-2003-interferon-granulopoiesis-signature-abstract.md
4. bennett-2003-interferon-granulopoiesis-signature-summary.md
5. campbell-2016-oxidized-mtdna-nets-sle-fulltext.txt
6. campbell-2016-oxidized-mtdna-nets-sle-paper.pdf
7. campbell-2016-oxidized-mtdna-nets-sle-summary.md
8. carriere-2020-low-density-neutrophils-sle-fulltext.txt
9. carriere-2020-low-density-neutrophils-sle-paper.pdf
10. carriere-2020-low-density-neutrophils-sle-summary.md
11. crispin-2010-pathogenesis-human-sle-fulltext.txt
12. crispin-2010-pathogenesis-human-sle-paper.pdf
13. crispin-2010-pathogenesis-human-sle-summary.md
14. deng-2011-genetic-susceptibility-sle-fulltext.txt
15. deng-2011-genetic-susceptibility-sle-paper.pdf
16. deng-2011-genetic-susceptibility-sle-summary.md
17. hartl-2021-dnase1l3-autoantibodies-fulltext.txt
18. hartl-2021-dnase1l3-autoantibodies-paper.pdf
19. hartl-2021-dnase1l3-autoantibodies-summary.md
20. kaplan-2013-nets-sle-fulltext.txt
21. kaplan-2013-nets-sle-paper.pdf
22. kaplan-2013-nets-sle-summary.md
23. kim-2015-pdc-ifn-axis-sle-fulltext.txt
24. kim-2015-pdc-ifn-axis-sle-paper.pdf
25. kim-2015-pdc-ifn-axis-sle-summary.md
26. lech-2013-lupus-nephritis-abstract.md
27. lech-2013-lupus-nephritis-summary.md
28. li-2019-neutrophil-diversity-sle-fulltext.txt
29. li-2019-neutrophil-diversity-sle-paper.pdf
30. li-2019-neutrophil-diversity-sle-summary.md
31. liu-2019-vdac-mtdna-lupus-fulltext.txt
32. liu-2019-vdac-mtdna-lupus-paper.pdf
33. liu-2019-vdac-mtdna-lupus-summary.md
34. macedo-2016-complement-classical-fulltext.txt
35. macedo-2016-complement-classical-paper.pdf
36. macedo-2016-complement-classical-summary.md
37. mahdavi-2018-tlr9-bcells-sle-abstract.md
38. mahdavi-2018-tlr9-bcells-sle-fulltext.txt
39. mahdavi-2018-tlr9-bcells-sle-paper.pdf
40. mahdavi-2018-tlr9-bcells-sle-summary.md
41. medgen-6146-sle-summary.md
42. medgen-6146-sle.html
43. obermoser-2010-interferon-alpha-signature-fulltext.txt
44. obermoser-2010-interferon-alpha-signature-paper.pdf
45. obermoser-2010-interferon-alpha-signature-summary.md
46. schwartz-2014-lupus-nephritis-pathogenesis-fulltext.txt
47. schwartz-2014-lupus-nephritis-pathogenesis-paper.pdf
48. schwartz-2014-lupus-nephritis-pathogenesis-summary.md
49. takeda-2018-tlr7-ifn-pdc-sle-abstract.md
50. takeda-2018-tlr7-ifn-pdc-sle-fulltext.txt
51. takeda-2018-tlr7-ifn-pdc-sle-paper.pdf
52. takeda-2018-tlr7-ifn-pdc-sle-summary.md
53. thim-2020-sting-lupus-fulltext.txt
54. thim-2020-sting-lupus-paper.pdf
55. thim-2020-sting-lupus-summary.md
56. zhang-2007-baff-tcells-sle-abstract.md
57. zhang-2007-baff-tcells-sle-summary.md